Table 1.
Clinical characteristics of study subjects.
Table 2.
Correlations between chemerin levels and other metabolic parameters (n = 92).
Table 3.
Risk of having a MetS component relative to chemerin and adiponectin levels.
Table 4.
Anthropometric and metabolic parameters relative to chemerin and adiponectin levels.
Table 5.
Risk of metabolic syndrome relative to chemerin and adiponectin levels.